Global Insulin Pumps Market Report and Forecast 2024-2032

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Insulin Pumps Market Overview 
    3.1    Global Insulin Pumps Market Historical Value (2017-2023) 
    3.2    Global Insulin Pumps Market Forecast Value (2024-2032)
4    Vendor Positioning Analysis
    4.1    Key Vendors
    4.2    Prospective Leaders
    4.3    Niche Leaders
    4.4    Disruptors
5    Global Insulin Pumps Market Landscape*
    5.1    Global Insulin Pumps: Developers Landscape
        5.1.1    Analysis by Year of Establishment
        5.1.2    Analysis by Company Size
        5.1.3    Analysis by Region
    5.2    Global Insulin Pumps: Product Landscape 
        5.2.1    Analysis by Product Type
6    Global Insulin Pumps Market Dynamics
    6.1    Market Drivers and Constraints
    6.2    SWOT Analysis
        6.2.1    Strengths
        6.2.2    Weaknesses
        6.2.3    Opportunities
        6.2.4    Threats
    6.3    PESTEL Analysis 
        6.3.1    Political 
        6.3.2    Economic 
        6.3.3    Social 
        6.3.4    Technological 
        6.3.5    Legal 
        6.3.6    Environment
    6.4    Porter’s Five Forces Model
        6.4.1    Bargaining Power of Suppliers
        6.4.2    Bargaining Power of Buyers
        6.4.3    Threat of New Entrants
        6.4.4    Threat of Substitutes
        6.4.5    Degree of Rivalry
    6.5    Key Demand Indicators 
    6.6    Key Price Indicators
    6.7    Industry Events, Initiatives, and Trends  
    6.8    Value Chain Analysis
7    Global Insulin Pumps Market Segmentation (2017-2032)
    7.1    Global Insulin Pumps Market (2017-2032) by Product Type
        7.1.1    Market Overview
        7.1.2    Insulin Pumps
            7.1.2.1    Tethered Pumps
            7.1.2.2    Disposable/Patch Insulin Pumps
        7.1.3    Insulin Pump Supplies and Accessories
            7.1.3.1    Insulin Reservoirs/Cartridges
            7.1.3.2    Infusion Set Insertion Devices 
    7.2    Global Insulin Pumps Market (2017-2032) by Indication
        7.2.1    Market Overview
        7.2.2    Type I Diabetes
        7.2.3    Type II Diabetes
    7.3    Global Insulin Pumps Market (2017-2032) by Distribution Channel
        7.3.1    Market Overview
        7.3.2    Hospital Pharmacy
        7.3.3    Retail Pharmacy
        7.3.4    Online Pharmacy
    7.4    Global Insulin Pumps Market (2017-2032) by Region
        7.4.1    Market Overview
        7.4.2    North America 
        7.4.3    Europe
        7.4.4    Asia Pacific
        7.4.5    Latin America
        7.4.6    Middle East and Africa
8    North America Insulin Pumps Market (2017-2032)
    8.1    North America Insulin Pumps Market (2017-2032) by Product Type
        8.1.1    Market Overview
        8.1.2    Insulin Pumps
            8.1.2.1    Tethered Pumps
            8.1.2.2    Disposable/Patch Insulin Pumps
        8.1.3    Insulin Pump Supplies and Accessories
            8.1.3.1    Insulin Reservoirs/Cartridges
            8.1.3.2    Infusion Set Insertion Devices 
    8.2    North America Insulin Pumps Market (2017-2032) by Indication
        8.2.1    Market Overview
        8.2.2    Type I Diabetes
        8.2.3    Type II Diabetes
    8.3    North America Insulin Pumps Market (2017-2032) by Distribution Channel
        8.3.1    Market Overview
        8.3.2    Hospital Pharmacy
        8.3.3    Retail Pharmacy
        8.3.4    Online Pharmacy
    8.4    North America Insulin Pumps Market (2017-2032) by Country
        8.4.1    United States of America
        8.4.2    Canada
9    Europe Insulin Pumps Market (2017-2032)
    9.1    Europe Insulin Pumps Market (2017-2032) by Product Type
        9.1.1    Market Overview
        9.1.2    Insulin Pumps
            9.1.2.1    Tethered Pumps
            9.1.2.2    Disposable/Patch Insulin Pumps
        9.1.3    Insulin Pump Supplies and Accessories
            9.1.3.1    Insulin Reservoirs/Cartridges
            9.1.3.2    Infusion Set Insertion Devices 
    9.2    Europe Insulin Pumps Market (2017-2032) by Indication
        9.2.1    Market Overview
        9.2.2    Type I Diabetes
        9.2.3    Type II Diabetes
    9.3    Europe Insulin Pumps Market (2017-2032) by Distribution Channel
        9.3.1    Market Overview
        9.3.2    Hospital Pharmacy
        9.3.3    Retail Pharmacy
        9.3.4    Online Pharmacy
    9.4    Europe Insulin Pumps Market (2017-2032) by Country
        9.4.1    United Kingdom
        9.4.2    Germany
        9.4.3    France
        9.4.4    Italy
        9.4.5    Others
10    Asia Pacific Insulin Pumps Market (2017-2032)
    10.1    Asia Pacific Insulin Pumps Market (2017-2032) by Product Type
        10.1.1    Market Overview
        10.1.2    Insulin Pumps
            10.1.2.1    Tethered Pumps
            10.1.2.2    Disposable/Patch Insulin Pumps
        10.1.3    Insulin Pump Supplies and Accessories
            10.1.3.1    Insulin Reservoirs/Cartridges
            10.1.3.2    Infusion Set Insertion Devices 
    10.2    Asia Pacific Insulin Pumps Market (2017-2032) by Indication
        10.2.1    Market Overview
        10.2.2    Type I Diabetes
        10.2.3    Type II Diabetes
    10.3    Asia Pacific Insulin Pumps Market (2017-2032) by Distribution Channel
        10.3.1    Market Overview
        10.3.2    Hospital Pharmacy
        10.3.3    Retail Pharmacy
        10.3.4    Online Pharmacy
    10.4    Asia Pacific Insulin Pumps Market (2017-2032) by Country
        10.4.1    China
        10.4.2    Japan
        10.4.3    India
        10.4.4    ASEAN
        10.4.5    Australia
        10.4.6    Others
11    Latin America  Insulin Pumps Market (2017-2032)
    11.1    Latin America Insulin Pumps Market (2017-2032) by Product Type
        11.1.1    Market Overview
        11.1.2    Insulin Pumps
            11.1.2.1    Tethered Pumps
            11.1.2.2    Disposable/Patch Insulin Pumps
        11.1.3    Insulin Pump Supplies and Accessories
            11.1.3.1    Insulin Reservoirs/Cartridges
            11.1.3.2    Infusion Set Insertion Devices 
    11.2    Latin America Insulin Pumps Market (2017-2032) by Indication
        11.2.1    Market Overview
        11.2.2    Type I Diabetes
        11.2.3    Type II Diabetes
    11.3    Latin America Insulin Pumps Market (2017-2032) by Distribution Channel
        11.3.1    Market Overview
        11.3.2    Hospital Pharmacy
        11.3.3    Retail Pharmacy
        11.3.4    Online Pharmacy
    11.4    Latin America Insulin Pumps Market (2017-2032) by Country
        11.4.1    Brazil
        11.4.2    Argentina
        11.4.3    Mexico
        11.4.4    Others
12    Middle East and Africa Insulin Pumps Market (2017-2032)
    12.1    Middle East and Africa Insulin Pumps Market (2017-2032) by Product Type
        12.1.1    Market Overview
        12.1.2    Insulin Pumps
            12.1.2.1    Tethered Pumps
            12.1.2.2    Disposable/Patch Insulin Pumps
        12.1.3    Insulin Pump Supplies and Accessories
            12.1.3.1    Insulin Reservoirs/Cartridges
            12.1.3.2    Infusion Set Insertion Devices 
    12.2    Middle East and Africa Insulin Pumps Market (2017-2032) by Indication
        12.2.1    Market Overview
        12.2.2    Type I Diabetes
        12.2.3    Type II Diabetes
    12.3    Middle East and Africa Insulin Pumps Market (2017-2032) by Distribution Channel
        12.3.1    Market Overview
        12.3.2    Hospital Pharmacy
        12.3.3    Retail Pharmacy
        12.3.4    Online Pharmacy
    12.4    Middle East and Africa Insulin Pumps Market (2017-2032) by Country
        12.4.1    Saudi Arabia
        12.4.2    United Arab Emirates
        12.4.3    Nigeria
        12.4.4    South Africa
        12.4.5    Others
13    Regulatory Framework
    13.1    Regulatory Overview
    13.2    US FDA
    13.3    EU EMA
    13.4    INDIA CDSCO
    13.5    JAPAN PMDA
    13.6    Others
14    Patent Analysis
    14.1     Analysis by Type of Patent
    14.2     Analysis by Publication Year
    14.3     Analysis by Issuing Authority
    14.4     Analysis by Patent Age
    14.5     Analysis by CPC Analysis
    14.6     Analysis by Patent Valuation 
    14.7     Analysis by Key Players
15    Funding and Investment Analysis
    15.1     Analysis by Funding Instances
    15.2     Analysis by Type of Funding
    15.3     Analysis by Funding Amount
    15.4     Analysis by Leading Players
    15.5     Analysis by Leading Investors
    15.6     Analysis by Geography
16    Strategic Initiatives
    16.1     Analysis by Partnership Instances
    16.2     Analysis by Type of Partnership
    16.3     Analysis by Leading Players
    16.4     Analysis by Geography
17    Supplier Landscape
    17.1    Market Share Analysis, By Region (Top 5 Companies)
        17.1.1    Market Share Analysis: Global
        17.1.2    Market Share Analysis: North America
        17.1.3    Market Share Analysis: Europe
        17.1.4    Market Share Analysis: Asia Pacific
        17.1.5    Market Share Analysis: Others
    17.2    Insulet Corporation 
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Company News and Developments
        17.2.5    Certifications 
    17.3    Medtronic Plc.
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Company News and Developments
        17.3.5    Certifications
    17.4    F. Hoffmann-La Roche AG 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Company News and Developments
        17.4.5    Certifications
    17.5    Tandem Diabetes Care, Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Company News and Developments
        17.5.5    Certifications
    17.6    Ypsomed AG 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Company News and Developments
        17.6.5    Certifications
    17.7    Ascensia Diabetes Care India Private Limited.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Company News and Developments
        17.7.5    Certifications
    17.8    Wuxi Apex Medical Co. Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Company News and Developments
        17.8.5    Certifications
    17.9    A. Menarini Diagnostics S.r.l 
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Company News and Developmentsl
        17.9.5    Certifications 
    17.10    Sooil Development Co., Ltd 
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Company News and Developments
        17.10.5    Certifications 
    17.11    Valeritas, Inc.
        17.11.1    Financial Analysis
        17.11.2    Product Portfolio
        17.11.3    Demographic Reach and Achievements
        17.11.4    Company News and Developments
        17.11.5    Certifications 
    17.12    JingasuDelfu Co., Ltd.
        17.12.1    Financial Analysis
        17.12.2    Product Portfolio
        17.12.3    Demographic Reach and Achievements
        17.12.4    Company News and Developments
        17.12.5    Certifications 
18    Global Insulin Pumps Market – Distribution Model (Additional Insight)
    18.1     Overview 
    18.2     Potential Distributors 
    18.3     Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)

*Additional insights provided are customisable as per client requirements.

* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.

**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.